Cape Bio Pharms
PrivateLast Round
Debt
Dec 18, 2020
Total Funding Raised
$44.57M
Company Overview
Cape Bio Pharms operates in Healthcare & Life Sciences and is based in Cape Town. Its latest recorded funding round was a Debt round in December 2020.
Cape Bio Pharms is a biotechnology company that develops and manufactures plant-based recombinant proteins for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cape Bio Pharms Comparables
Compare Cape Bio Pharms with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leaf Expression Systems | 88% | |
| Zea Biosciences | 81% | |
| Agrenvec | 80% |
For institutional investors. Book with your work email.
Cape Bio Pharms Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 18, 2020 | ||||
| Seed | Jul 28, 2020 | ||||
| Grant | Mar 31, 2015 |
For institutional investors. Book with your work email.
Cape Bio Pharms Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technology Innovation Agency | Seed, Grant |
| Allan Gray E2 Ventures | Seed |
| SA SME Fund | Seed |
| Foundation for Innovative New Diagnostics | Debt |
| European Investment Bank Group | Debt |
| kENUP Foundation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 119% MoM, reaching 1.5K.
- Jul 2, 2025
Monthly visitors increased 139% MoM.
For institutional investors. Book with your work email.
Cape Bio Pharms Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cape Bio Pharms's valuation, stock price, and market status.
Is Cape Bio Pharms a public or private company?
Cape Bio Pharms is a private company.
What is the current stock price of Cape Bio Pharms?
Cape Bio Pharms is a private company, so its shares have no public market price. Caplight tracks Cape Bio Pharms's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cape Bio Pharms worth (valuation)?
Valuation information for Cape Bio Pharms is not publicly available.
Can I buy Cape Bio Pharms stock?
Cape Bio Pharms shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cape Bio Pharms's last funding round?
Cape Bio Pharms's most recent funding round was Debt on December 18, 2020.
Who are the main investors in Cape Bio Pharms?
Key investors in Cape Bio Pharms include Technology Innovation Agency, European Investment Bank Group.
Will Cape Bio Pharms IPO soon?
No public IPO plans have been announced for Cape Bio Pharms.
How can I track Cape Bio Pharms secondary market activity?
Caplight tracks bids, offers, and trades in Cape Bio Pharms's shares on secondary markets.